Диссертация (1139867), страница 18
Текст из файла (страница 18)
// Eur J Cardiovasc Prev Rehabil.-2003.- Vol.10.Р.1-10.95.Fariborz, M. The Effects of Smoking on Levels of Endothelial ProgenitorCells and Microparticles in the Blood of Healthy Volunteers/ Fariborz Mobarrez atal. // PLOS ONE.-2014.- Vol. 9.-Р.1-7.96.Ferder, L.
Inflammation and the metabolic syndrome: role of angiotensin IIand oxidative stress /Ferder L, Inserra F, Martinez-Maldonado M. //Curr HypertensRep.- 2006.- Vol.8.-Р.191-20997.Fernanda, Moura Vargas Dias. Na+K+-ATPase Activity and K+ ChannelsDifferently Contribute to Vascular Relaxation in male and female Rats/ FernandaMoura Vargas Dias, Rogério Faustino Ribeiro Júnior, Aurélia Araújo Fernandes etal.//PLoS One.-2014.- Vol.99.-Р.106-11898.Figtree, G.A. Truncated estrogen receptors alpha 46-kDa isoform in humanendothelial cells: Relation to acute activation of nitric oxide synthase/ Figtree GA,123McDonald D, Watkins H, Channon KM.
// Circulation.- 2003.- Vol.107.-Р.120-126.99.Furchgott, R.F. The obligatory role of endothelial cells in the relaxation ofarterial smooth muscle by acetylcholine / Furchgott RF., Zawadzki JV. //Nature1980.- Vol.9.-Р.18-118100. Gandotra, P. The role of triglycerides in cardiovascular risk/ Gandotra P,Miller M. //Current Cardiol Rep.- 2008.- Vol.10.-505–511.101. Garland, C.J. EDHF: spreading the influence of the endothelium./ GarlandCJ, Hiley CR, Dora KA // Br J Pharmacol.-2011.- Vol.164.-Р.
839–852102. Gerova, M. Nitric oxide compromised hypertension: facts and enigmas/Gerova M. //Heart and circulatory physiology.-2000.- Vol.49.- P.27-35103. Ghasemi, A. Serum nitric oxide metabolite levels in a general healthypopulation: relation to sex and age. /Ghasemi A, Zahedi Asl S, Mehrabi Y et al.//Life Sci. -2008.- Vol.29.- Р.326-331104.
Ghasemi, A. Reference values for serum nitric oxide metabolites in an adultpopulation/ Ghasemi A, Zahediasl S, Azizi F// Clin Biochem.-2010.-Vol.43.- Р.8994.105. Ghasemi, A. Nitric oxide and clustering of Metabolic syndrome componentsin pediatrics / Ghasemi A, Zahediasl S, Azizi F. //Eur J Epidemiol.- 2010.- Vol.25.Р.45–53.106. Ghiadoni, L. Different effect of antihypertensive drugs on conduit arteryendothelial function/Ghiadoni L,Magagna A,Versari D., et al. //Hypertension.2003.- Vol.
41.-Р.1281-1286107. Ghiadoni, L. Metabolic syndrome and vascular alterations in normotensivesubjects at risk of diabetes mellitus/ Ghiadoni L, Penno G, Giannarelli C, et al. //Hypertension.- 2008.- Vol.51.-Р.440–5108. Giannarelli, C. Tissue-type plasmnogen activator release in healthy subjectsand hyperensive patients: relationship with beta-adrenergic receptors and the nitricoxide pathway/Giannarelli C, Virdis A, De Negri F, et al. // Hypertension.-2008.Vol.52.-Р.314-21124109.Giuntoli, F.Combination of an ACE inhibitor and indapamide improvesblood pressure control, but attenuates the beneficial effects of ACE inhibition onplasma adiponectin in patients with essential hypertension /Giuntoli F.,Huang SS,et al //Circ J.- 2009.- Vol.73.-Р. 2282-2287110. Giustarini, D.
Nitric oxide and S-nitrosothiols in human blood / GiustariniD., Milzani A., Colombo R. et al. // Clinica Chimica Acta.- 2003.- Vol. 330. -P. 8598111. Golan, E. Reduction in Resting Metabolic Rate and Ratio of Plasma Leptinto Urinary Nitric Oxide: Influence on Obesity-Related / Golan E., Tal B., Dror Y.,et al.//Hypertension IMAJ.- 2002.- Vol.4.-Р.426-430112. Goldstein, B.J. Adiponectin: a novel adipokine linking adipocytes andvascular function.
/ Goldstein BJ, Scalia R. //J Clin Endocrinol Metab.- 2004.Vol.89.-Р.2563–8.113. Govindarajan, G. et al. Obesity and hypertension: A clinical update.Molecular Mechanisms in Hypertension / Govindarajan G. et al // Taylor andFrancis Pub, London.- 2006.- Vol.15.- Р. 397–406.114. Granger, J.
An emerging role for inflammatory cytokines in hypertension./Granger J.// Physiol. Res.-2006.- Vol.290.-P.923-925115. Grieve, D.J. Divergent biological actions of coronary endothelial nitricoxide during progression of cardiac hypertrophy/ Grieve DJ MacCarthy PA, GallNP et al. // Hypertension.-2001.-№38.- P.267-273116. Gruber, H.J. Obesity reduces the biovailability of nitric oxide in juveniles./Gruber HJ, Mayer C, Mangge H, et al // Int J Obes Lond.- 2008.- Vol.32.-Р.826–831117.
Guidelines Committee ESH-ESC.- 2013 ESH-ESC guidelines for themanagement of arterial hypertension.// J Hypertension 2013.- Vol.31.- Р.12811357.118. Guo, X. Effect of cigarette smoking on nitric oxide, structural, andmechanical properties of mouse arteries / GuoX, Oldham M Kleinman M et al.//Am J Physiol Heart Circ Physiol.-2006.-Vol.219.-P. 2354-2361125119. Haynes, W.G. Endothelin as a regulator of cardiovascular function in healthand disease/ Haynes WG Webb DJ //Hypertension.-1998.- Vol.16.-P.1081-1098120.
Higashino, H. Serum nitric oxide metabolite (NO(x)) levels in hypertensivepatients at rest: a comparison of age, gender, blood pressure and complicationsusing normotensive controls/Higashino H, Miya H, Mukai H et al. // Clin ExpPharmacol Physiol.- 2007.-Vol.34.-Р.725-31.121. Higashi, Y. Circadian variation of blood pressure and endothelial function inpatients with essential hypertension: a comparison of dippers and non-dippers/Higashi Y, Nakagawa K, at al // J Am Coll Cardiol.- 2002.- Vol.4.-Р.40-51122. Hong, H.
Suppression of the development of hypertension by the inhibitor ofinducible nitric oxide synthase /Hong H.-J, Loh S.-H. and Yen M.-H. // Br JPharmacol.- 2000.- Vol.131.- Р. 631-637.123. Hori, T. Relationship between endothelial dysfunction and nitric oxideproduction in young male smokers / Hori T, Matsubara T et al. //J Cardiol.-2001.Vol.38.-P. 21-8124.
Hu, F.B. Insulin resistance and hypertension: the chicken-egg questionrevisited/ Hu FB, Stampfer MJ // Circulation.- 2005.- Vol.112.- Р.1678–80.125. Huang, K.T. Modulation of nitric oxide bioavailability by erythrocytes. /Huang KT, Han TH, Hyduke DR, et al.//Proc Natl Acad Sci U S A. -2001.Vol.98.-Р.11771–11776126. Ichikawa, T. Peroxynitrite augments fibroblast mediated tissue remodelingvia myofibroblast differentiation / Ichikawa T., Sugiura H., Koarai A.
et al // Am. J.Physiol. Lung. Cell. Mol. Physiol.- 2008.- Vol.295.- № 5.- P. 800—808.127. Iida, M. Predictive value of von Willebrand factor for adverse clinicaloutcome in hypertensive patients with mild-to-moderate aortic regurgitation./ IidaM, Nihei M, Yamazaki M et al // J Hum Hypertens.- 2008.- Vol.22.- Р.275-81.128. Jaime, González Essential hypertension and oxidative stress: Newinsights/JaimeGonzález, NicolásValls, RobertoRodrigo//World J Cardiol.- 2014.-Vol.26 Р.
353–366.126Brito,and Ramón129. Jeong-Ho, Oak Attenuation of Angiotensin II Signaling Recouples eNOSand Inhibits Nonendothelial NOX Activity in Diabetic /Jeong-Ho Oak and Hua Cai//Diabetes.- 2007.- Vol.56.- Р 47-62130. Jianping, Ye/ Adipose Tissue Vascularization: Its Role in ChronicInflammation/Jianping Ye/// Curr Diab Rep.- 2011.- Vol.11.- Р. 203–210.131. John, Lekakis. Methods for evaluating endothelial function: a positionstatement from the European Society of Cardiology Working Group on Peripheral/John Lekakis1, Pierre Abraham, at al //Circulation European Journal ofCardiovascular Prevention & Rehabilitation.- 2011.- Vol. 8.-Р 12-31132. Judith, L. Vaughan/ Endothelial biology in the post-menopausal obesewoman/Judith L.
Meadows, Douglas E. Vaughan // Maturitas.- 2011.- Vol.69.- Р.120–125133. Kalyani, R.R. Androgen deficiency, diabetes, and the metabolic syndrome inmen. Curr. Opin. Endocrinol. / Kalyani, R.R., Dobs, A.S. //Diabetes. Obes.- 2007.Vol.14.- Р. 226–234.134. Kim, S.F. Inducible nitric oxide synthase binds, S-nitrosylates, and activatescyclooxygenase-2 / Kim S.F., Huri D.A., Snyder S.H.// Science.- 2005.- Vol. 310.P. 1966—1970.135. Killburn K.N.
Stop inhaling smoke: prevent coronary heart disease. /Killburn K.N. //Arch Environ Health.-2003.- Vol.58.-P68-73136. Kocak H. Serum asymmetric dimehylarginine and nitric oxide levels inobese postmenopausal women./ Kocak H, Oner-Iyidogan Y, Gurdol F., Oner P,Esin D // J Clin Lab Anal.- 2011.- Vol.25.-Р.174-8137. Korda, M. Leptin-induced endothelial dysfunction in obesity. Am. J.Physiol. / Korda M, Kubant R, Patton S, Malinski T. // Heart Circ.
Physiol.- 2008.Vol. 295.-Р.1514–21138. Kusnoor, A.V. Ischemic Heart Disease in Women: A Review for PrimaryCare Physicians. / Kusnoor A.V., Ferguson A.D., Falik R. //South Med .-J 2011.Vol.104.-Р. 200-204127139. Kylin E. Studien uber das Hypertonie, Hyperglicamie, Hyperuricamie –syndrome E. Kylin/ Kylin E. //Zentralbl Inner Med.-1923.- Vol.57.-Р. 105-112140. Lekontseva, O. Endothelin in the female vasculature: a role in aging? /Lekontseva O, Chakrabarti S, Davidge T. // Am J Physiol Regul Integr CompPhysiol.- 2010.- Vol.298.-Р.509-16.141.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
